Trial description:
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in High Grade Undifferentiated Uterine Sarcoma (HGUS) after stabilization or response to doxorubicin +/- ifosfamide following surgery or in metastatic first line treatment
Contact name:
Dr Helen Hatcher
Trial start date:
Friday, March 11, 2016
Trial end date:
Monday, December 30, 2019
Trial tumour type:
Sarcoma
Show on Radiotherapy:
No